Zujie Mao

Hangzhou Medical College

Papers

1

Total Citations

5

H-Index

1

About

Zujie Mao is a pioneering figure in the field of robotic-assisted urological surgery, with a focused expertise in minimally invasive techniques for prostate and kidney cancer treatment. His most-cited work, a 2025 comparative study, rigorously evaluates the clinical efficacy of the da Vinci surgical system against the emerging Toumai® robotic platform for robot-assisted radical prostatectomy and partial nephrectomy. This research provides critical, evidence-based insights into the performance and safety of next-generation surgical robots, directly informing surgical decision-making and advancing the adoption of cost-effective, domestically developed technologies. With his work already garnering early citations, Mao is establishing a significant impact in the rapidly evolving landscape of surgical robotics. His contributions are particularly notable for bridging the gap between established global systems and innovative local alternatives, a crucial step for expanding access to high-quality robotic surgery worldwide.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of efficacy between the da Vinci surgical system and Toumai® robotic surgical systems for robot-assisted radical prostatectomy and robot-assisted partial nephrectomy
5 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Hangzhou Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago